ASCO Genitourinary Cancers Symposium


 

ARASENS Trial Updates: OS With Darolutamide vs. Placebo in Combination With ADT & Docetaxel for mHSPC

366 views
March 8, 2022
0 Comments
Login to view comments. Click here to Login